AKBA R&D to Revenue
Akebia Therapeutics Inc · R&D to Revenue
AKBA R&D to Revenue
Latest reported28.62%period ending
AKBA Quarterly R&D/Revenue (0.00% → 28.62%)
Latest values, visible window
High-resolution chart · PNG
AKBA r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 28.6171% | |
| 27.6539% | |
| 46.2478% | |
| 24.8885% | |
| 17.6287% | |
| 17.012% | |
| 25.3479% | |
| 22.6755% | |
| 17.5197% | |
| 29.8433% | |
| 17.5546% | |
| 31.7034% | |
| 35.8255% | |
| 49.2088% | |
| 57.8181% | |
| 57.5358% | |
| 20.5967% | |
| 71.0433% | |
| 51.244% | |
| 83.0072% | |
| 70.3305% | |
| 77.6442% | |
| 66.2763% | |
| 78.1106% | |
| 58.5953% | |
| 91.8093% | |
| 115.6092% | |
| 81.0116% | |
| 85.0114% | |
| 113.3281% | |
| 145.5522% | |
| 132.8481% | |
| 147.392% | |
| 133.6904% | |
| 78.3155% | |
| 142.2159% | |
| 153.4046% | |
| 287.7977% | |
| 2,178.1759% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |